Skip to main content
. 2020 Dec 5;17(23):9096. doi: 10.3390/ijerph17239096

Table A3.

Characteristics of studies meeting the search inclusion criteria.

Author/Year Sample Size Country Health Care Workers Male (%) Survey Tool Cut-Off Outcomes (%) (n)
Physician (%) Nurses (%) Depression Anxiety Insomnia Stress PTSD a Distress
Aksoy and Kocak et al., 2020 [81] 758 Turkey 0.0 100.0 7.0 STAI y NA ae NA 36.3
(275)
NA NA NA NA
Alshekaili et al., 2020 [44] 1139 Oman 33.7 39.4 20.0 DASS t -21(D aa)
DASS t -21(A ab)
DASS t -21(S ac)
ISI d
≥10
≥8
≥16
≥14
32.3
(368)
34.1
(388)
18.5
(211)
23.8
(271)
NA NA
Amerio et al., 2020 [45] 131 Italy NA NA 51.9 PHQ c -9 ≥10 39.3
(30)
NA NA NA NA NA
Amin et al., 2020 [37] 250 Pakistan 49.2 30.4 63.6 PGWBI l ≥30 NA NA NA NA NA 72.4
(181)
An et al., 2020 [46] 1103 China 0.0 100.0 9.2 PHQ c -9 ≥5 43.6
(481)
NA NA NA NA NA
Cai et al., 2020 [79] 2346 China NA NA 29.9 PHQ c -9
BAI m
ISI d
≥10
≥15
≥9
12.23
(287)
11.6
(271)
38.4
(902)
NA NA NA
Caliskan et al., 2020 [47] 290 Turkey 100.0 NA 61.7 HADS k -D
HADS k -A
≥7
≥10
62.1
(180)
35.5
(103)
NA NA NA NA
Cao et al., 2020 [33] 37 China 16.0 19.0 21.6 PHQ c -9 ≥10 18.9
(7)
NA NA NA NA NA
Chatterjee et al., 2020 [48] 152 India NA NA 78.3 DASS t -21 NA 34.9
(53)
39.5
(60)
NA 32.9
(50)
NA NA
Chen et al., 2020 [30] 105 China NA NA 9.5 SAS r
SDS z
≥50
≥50
29.5
(31)
18.1
(19)
NA NA NA NA
Chew et al., 2020 [34] 906 Singapore and India NA NA NA DASS t -21(D aa)
DASS t -21(A ab)
DASS t -21(S ac)
IES i -R
>9
>7
>14
≥24
21.4
(96)
31.5
(142)
NA 10.3
(47)
14.8
(67)
NA
Chung and Yeung et al., 2020 [78] 69 Hong Kong 4.4 34.8 NA PHQ c -9 ≥10 49.3
(34)
NA NA NA NA NA
Civantos et al., 2020 [49] 349 USA 52.7 NA 60.7 GAD b -7
PHQ c -2
IES i
≥10
≥3
≥27
10.6
(37)
47.9
(167)
NA NA NA 60.2
(210)
Consolo et al., 2020 [35] 356 Italy NA NA 60.4 GAD b -7 ≥5 NA 57.0
(204)
NA NA NA NA
Corbett et al., 2020 [50] 240 Dublin Ireland 15.0 36.25 9.2 GAD b -7
PHQ c -9
≥10
≥10
20.3
(49)
21.0
(51)
NA NA NA NA
Dai et al., 2020 [51] 4357 China 32.6 53.8 23.5 GHQ e -12 ≥3 NA NA NA NA NA 39.1
(1704)
Dal’Bosco et al., 2020 [52] 88 South America NA NA 10.2 HAD k ≥3 25.0
(22)
48.9
(43)
NA NA NA NA
Dong et al., 2020 [53] 4618 China 24.6 62.7 16.3 HEI q ≥8 NA NA NA NA NA 24.2
(1118)
Du et al., 2020 [20] 134 China 35.1 41.0 39.6 BDI o -II
BAI m
PSS j
≥14
≥8
≥14
12.7
(17)
20.1
(28)
NA 59.0
(79)
NA NA
Elbay et al., 2020 [54] 442 Turkey NA NA 43.2 DASS t -21(D aa)
DASS t -21(A ab)
DASS t -21(S ac)
>9
>7
>14
64.7
(286)
51.6
(224)
NA 41.2
(182)
NA NA
Guiroy et al., 2020 [36] 204 Latin America ad 100.0 NA 96.6 PHQ c -9 ≥10 100
(204)
NA NA NA NA NA
Guo et al., 2020 [23] 11,118 China 30.28 53.07 25.2 SAS r
SDS z
≥50
≥50
31.5
(3497)
17.5
(1940)
NA NA NA 40.7
(4530)
Hassannia et al., 2020 [55] 487 Iran 26.08 21.56 NA HADS k -D aa
HADS k -A ab
≥8
≥8
48.3
(235)
62.8
(306)
NA NA NA NA
Hawari et al., 2020 [56] 1006 Jordan 13.02 63.02 44.7 K6 ag ≥11 NA NA NA NA NA 96.5
(971)
Hu et al., 2020 [57] 2101 China NA 100.00 12.4 SAS r
ZSDS v
≥50
≥60
42.0
(878)
40.0
(833)
NA NA NA 41.5
(835)
Huang and Zhao et al., 2020 [25] 2250 China NA NA NA GAD b -7
CES-D s
PSQI p
≥9
≥28
≥7
19.8
(446)
35.6
(802)
23.6
(531)
NA NA NA
Huang et al., 2020 [24] 230 China 30.4 69.6 18.7 SAS r
PTSD-SS
≥50
≥50
NA 23.0
(53)
NA NA 27.4
(63)
NA
Jahrami et al., 2020 [58] 257 Bahrain 31.1 46.3 30.0 PSQI p
PSS j
≥5
≥14
NA NA NA 100.0
(257)
NA NA
Kang et al., 2020 [39] 994 China 18.4 81.6 14.5 PHQ c -9
GAD b -7
ISI d
IES i -R
≥5
≥5
≥8
≥9
63.0
(627)
NA NA NA NA NA
Kaveh et al., 2020 [43] 1038 Iran 20.6 63.3 12.4 BAI m ≥7 NA 100.0
(1038)
NA NA NA NA
Khanna et al., 2020 [59] 2355 India NA NA 56.6 PHQ c -9 ≥4 32.6
(765)
NA NA NA NA NA
Koksal et al., 2020 [80] 702 Turkey NA 48.3 30.0 HADS k -D aa
HADS k -A ab
≥7
≥10
36.9
(259)
57.5
(404)
NA NA NA NA
Lai et al., 2020 [16] 1257 China 39.2 60.8 23.3 PHQ c -9
GAD b -7
ISI d
IES i -R
≥5
≥5
≥8
≥9
50.4
(634)
44.6
(560)
34
(427)
NA NA 71.5
(899)
Li et al., 2020 [31] 4369 China 13.3 77.4 0.0 IES i –R
PHQ c -9
GAD b -7
≥33
≥10
≥8
14.2
(621)
25.2
(1101)
NA 31.6
(1382)
NA NA
Liu et al., 2020 [27] 512 China NA NA 15.4 SAS r ≥50 NA 12.5
(64)
NA NA NA NA
Liu et al., 2020 [28] 4679 China 39.6 60.4 17.7 SAS r
SDS z
SRQ x -20
≥50
≥50
≥7
34.6
(1619)
16.0
(749)
NA NA NA 15.9
(744)
Lu et al., 2020 [19] 2299 China 88.8 NA 22.4 HADS k -D aa
HADS k -A ab
≥7
≥7
11.7
(268)
24.7
(569)
NA NA NA NA
Nair et al., 2020 [60] 586 India NA NA 53.1 CPDI w
PSS j
≥28
≥13
NA NA NA 100.0
(586)
NA 52.0
(304)
Naser et al., 2020 [61] 1163 Jordan 48.2 13.0 43.9 GAD b -7
PHQ c -9
≥4
≥5
78.0
(907)
71.0
(823)
NA NA NA NA
Podder et al., 2020 [62] 384 India NA NA 55.5 PSS j -10 ≥13 NA NA NA 100
(384)
NA NA
Qi et al., 2020 [26] 1306 China NA NA 19.6 PSQI p
AIS f
>7
>6
NA NA 45.5
(594)
NA NA NA
Que et al., 2020 [63] 2285 China 37.6 9.1 30.9 GAD b -7
PHQ c
ISI d
≥10
≥10
≥15
44.4
(1014)
46.0
(1052)
28.8
(657)
NA NA NA
Rossi et al., 2020 [64] 1379 Italy 37.64 34.23 22.8 GPS
PHQ c -9
GAD b -7
ISI d -7
PSS j -10
≥3
≥15
≥15
≥22
NA
24.73
(341)
19.8
(273)
8.3
(114)
21.9
(302)
49.4
(681)
NA
Salman et al., 2020 [65] 398 Pakistan 51.5 33.4 46.0 GAD b -7
PHQ c -9
≥10
≥10
21.9
(87)
21.4
(85)
NA NA NA NA
Shacham et al., 2020 [38] 338 Israel NA NA 41.4 K6 ag ≥19 NA NA NA NA NA 11.5
(39)
Shechter et al., 2020 [66] 657 USA 28.8 47.6 21.8 PC-PTSD u
PHQ c -2
GAD b -2
≥3
≥3
≥3
48.0
(313)
33.0
(215)
NA 57.0
(371)
NA NA
Stojanov et al., 2020 [67] 201 Serbia NA 100.0 34.3 GAD b -7
ZSDS v
≥5
≥50
30.8(62) 48.2
(97)
NA NA NA NA
Sun et al.,2020 [77] 320 China NA NA NA PCL af -5 ≥33 NA NA NA NA 4.4
(14)
NA
Tan et al., 2020 [21] 470 Singapore 28.7 34.3 31.7 DASS t -21(D aa)
DASS t -21(A ab)
DASS t -21(S ac)
IES i -R
>9
>7
≥14
≥24
8.9
(42)
14.5
(68)
NA 6.6
(31)
7.7
(36)
NA
Temsah et al., 2020 [6] 582 Saudi Arabian 18.6 62.4 24.9 GAD b -7 ≥5 NA 100.0
(582)
NA NA NA NA
Teng et al., 2020 [68] 398 China NA NA 24.1 PHQ c -9
SAS r
≥5
≥50
35.9
(143)
14.1
(56)
NA NA NA NA
Thapa et al., 2020 [69] 100 Nepal 9.0 62.0 22.0 SAS r ≥45 NA 34.0
(34)
NA NA NA NA
Tu et al., 2020 [70] 100 China NA 100.0 0.0 GAD b -7
PHQ c -9
PSQI p
≥4
≥4
≥7
46.0
(46)
40.0
(40)
NA NA NA NA
Wang et al., 2020 [71] 1045 China 14.3 74.0 14.2 HADS k -D aa
HADS k -A ab
PSS j -14
ISI d
≥8
≥8
≥14
≥14
53.0
(554)
67.8
(708)
10.4
(109)
21.0
(223)
NA NA
Weilenmann et al., 2020 [72] 1410 Switzerland 60.8 39.2 33.8 GAD b -7
PHQ c -9
≥10
≥10
20.7
(292)
25.9
(365)
NA NA NA NA
Xiao et al., 2020 [73] 958 China 39.5 37.5 32.8 HADS k -D aa
HADS k -A ab
≥8
≥8
57.3
(549)
54.2
(518)
NA NA NA NA
Yang et al., 2020 [74] 65 South Korea NA NA 52.3 GAD b -7
PHQ c -9
≥5
≥10
18.5
(12)
32.3
(21)
NA NA NA NA
Yin et al., 2020 [75] 371 China 18.1 71.2 38.5 PCL af -5 ≥33 NA NA NA NA 3.8
(14)
NA
Zhan et al., 2020 [76] 1794 China NA 100.0 3.0 AIS f
FS g 14
CPSS h
≥6
≥7
≥25
NA NA 52.8
(948)
44.0
(789)
NA NA
Zhang et al., 2020 [17] 2182 China 31.2 11.3 35.8 ISI d
SCL n -90-R
PHQ c -2
GAD b -2
>8
≥2
≥3
≥3
10.6
(232)
10.4
(228)
33.9
(739)
NA NA NA
Zhang et al., 2020 [18] 1563 China 29.0 62.9 17.3 ISI d
PHQ c -9
GAD b -7
IES i -R
≥8
≥5
≥5
≥9
50.7
(792)
44.7
(699)
36.1
(564)
73.4
(1147)
NA NA
Zhang et al., 2020 [29] 304 Iran NA NA NA PHQ c -4
K6 ag
NA
NA
20.6
(63)
28.0
(85)
NA NA NA 20.1
(61)
Zhu et al., 2020 [41] 5062 China 19.8 67.5 15.0 IES i -R
PHQ c 9
GAD b -7
≥33
≥10
≥8
13.5
(681)
24.1
(1218)
NA 29.8
(1509)
NA NA
Zhu et al., 2020 [42] 165 China 47.9 52.1 17.0 SAS r
SDS z
≥50
≥50
44.2
(73)
20.0
(33)
NA NA NA NA

a PTSD: Post-traumatic stress syndrome, b GAD: Generalized anxiety disorder scale, c PHQ: Patient health questionnaire, d ISI: Insomnia severity index, e GHQ: General health questionnaire, f AIS: Athens insomnia scale, g FS: Fatigue scale, h CPSS: Chinese perceived stress scale, i IES: Impact of event scale, j PSS: Perceived stress scale, k HAD: Hospital anxiety depression scale, l PGWBI: Psychological General Well-Being Index, m BAI: Beck anxiety Inventory, n SCL-19-R: Symptom checklist, o BDI: Beck depression inventory, p PSQI: Pittsburgh sleep quality index, q HEI: Huaxi emotional distress index, r SAS: Self-rating anxiety scale, s CES-D: The center for epidemiology scale for depression, t DASS: Depression, anxiety, stress scales, u PC-PTSD: Primary care PTSD Screen, v Zsds: Zung self-rating depression scale, w CPDI: COVID-19 Peri traumatic distress index, x SRQ: Self reporting questionnaire, y STAI: State-trait anxiety inventory, z SDS: Self-rating depression scale, aa D: Depression, ab A: Anxiety, ac S: Stress, ad Latin America: Countries included Brazil, Argentina, Chile, and Mexico, ae NA: Not applicable, af PCL: Post-traumatic stress disorder checklist, ag K6—Kessler Phycological Distress Scale.